JavaScript NENÍ povolen !

Prosím povolte JavaScript.

* Zobrazit nápovědu

Autor: Riches, John C

2 záznamů v Medvik Filtry

Článek

Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era

Edelmann, Jennifer
Autor Edelmann, Jennifer ClinSciNet - The Clinician Scientist Network, Münsingen, Germany
Malcikova, Jitka
Autor Malcikova, Jitka Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Masaryk University, Brno, Czechia Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czechia
Riches, John C
Autor Riches, John C Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom Department of Haemato-Oncology, Barts Health NHS Trust, St. Bartholomew's Hospital, London, United Kingdom

Frontiers in oncology. 2023 ; 13 (-) : 1106579. [pub] 20230209

Front Oncol
ISSN 2234-943X
Medvik
Zdroj

Publikační typ
časopisecké články MeSH

Článek

Editorial: Biology and treatment of high-risk CLL

Frontiers in oncology. 2022 ; 12 (-) : 1109950. [pub] 20230220

Front Oncol
ISSN 2234-943X
Medvik
Zdroj

Publikační typ
úvodníky MeSH